TAVR in Low-Risk Patients: FDA Approval, the New NCD, and Shared Decision-Making. Coylewright M, Forrest JK, McCabe JM, Nazif TM, et al. J Am Coll Cardiol 2020;75:1208-1211.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Coylewright M, Forrest JK, McCabe JM, Nazif TM, et al. TAVR in Low-Risk Patients: FDA Approval, the New NCD, and Shared Decision-Making. J Am Coll Cardiol 2020;75:1208-1211.
PMID: 32164894